Leerink Swann Downgrades Abbott Labs (ABT) to Market Perform, Fully Valued Ahead of Split
Tweet Send to a Friend
Leerink Swann downgraded Abbott Labs (NYSE: ABT) from Outperform to Market Perform and adjusts its valuation range from $70 to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
